Ajinomoto Genexine CELLiST, challenge for self-sufficiency of advanced bio cell culture medium
페이지 정보
작성자 ajinomo 조회 219 작성일 22-06-07 17:28본문
Ajinomoto Genexine announced that it is attempting to become self-sufficient as a medium for cutting-edge
biopharmaceuticals through the development of a serum-free chemical composition medium.
Ajinomoto Genexine is a company jointly established in 2012 by Ajinomoto and bio venture Genexine to develop and
manufacture animal cell culture media and provide consignment production services. Local production of cell culture medium has been achieved.
In addition, through the CELLiST series, Ajinomoto Genexine is introducing cell culture media containing high-quality
amino acid technology.
The serum-free chemical composition medium that Ajinomoto Genexine is developing to become self-sufficient as a medium for cutting-edge biopharmaceuticals does not contain animal-derived substances, ensuring high safety, and
is easy to industrialize because the composition can be specified.
However, considering the fact that it is not easy to change from an existing cell culture medium to another, CELLiST
has provided active support through the switch program to increase development and production efficiency.
CELLiST's switch program does not charge separate product development costs for changing cell culture medium, and supports experiments using various instruments such as ambr, HPLC, and UPLC owned by Ajinomoto Genexine. We
also actively support document-related tasks such as equivalency approval and direct submission of composition to
the licensing agency.
An official from the company said, “If the serum-free chemical composition medium succeeds in becoming
self-sufficient as a medium for advanced biopharmaceuticals, it will facilitate the supply and demand of media for
domestic pharmaceutical and bio companies and greatly contribute to the rapid localization of all processes.” “We ask
for your interest in CELLiST’s switch program, which can supply the optimal cell culture medium to meet your needs.”
댓글목록
등록된 댓글이 없습니다.